Literature DB >> 12885281

Untreated hypertension among Australian adults: the 1999-2000 Australian Diabetes, Obesity and Lifestyle Study (AusDiab).

Esther M Briganti1, Jonathan E Shaw, Steven J Chadban, Paul Z Zimmet, Timothy A Welborn, John J McNeil, Robert C Atkins.   

Abstract

OBJECTIVE: To measure the prevalence of untreated hypertension in Australian adults, and examine the associations with clinical and lifestyle factors.
DESIGN: AusDiab, a cross-sectional survey conducted between May 1999 and December 2000, involved participants from 42 randomly selected census districts throughout Australia. PARTICIPANTS: Of 20 347 eligible people aged >or= 25 years who completed a household interview, 11 247 attended a physical examination (response rate, 55%). MAIN OUTCOME MEASURES: The prevalence of hypertension (blood pressure >or= 140/90 mmHg or self-reported use of antihypertensive drugs) and its treatment; associations of clinical and lifestyle factors with the treatment of hypertension; and adequacy of treatment for primary and secondary prevention of cardiovascular disease.
RESULTS: The prevalence of hypertension was 28.6 per 100 (95% CI, 25.0-32.3), and the prevalence of untreated hypertension was 15.2 per 100 (95% CI, 13.2-17.2). Of those with untreated hypertension, 80.8% (95% CI, 74.7%-85.0%) had had a blood pressure check within the preceding 12 months. At least one modifiable lifestyle factor was present in 71.7% (95% CI, 68.5%-74.8%) of participants with untreated hypertension. Although lower risk clinical characteristics of younger age and lack of hyperlipidaemia were independently associated with untreated hypertension, 53.5% warranted treatment based on current cardiovascular disease prevention guidelines and multivariable absolute risk assessment.
CONCLUSIONS: Considerable scope remains for reducing the burden of cardiovascular disease through lifestyle modification and rational treatment of hypertension.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12885281     DOI: 10.5694/j.1326-5377.2003.tb05114.x

Source DB:  PubMed          Journal:  Med J Aust        ISSN: 0025-729X            Impact factor:   7.738


  31 in total

1.  Economic and safety benefits of pharmaceutical interventions by community and hospital pharmacists in Japan.

Authors:  Yuichi Tasaka; Daiki Yasunaga; Mamoru Tanaka; Akihiro Tanaka; Takashige Asakawa; Ikuo Horio; Yoshiro Miyauchi; Hiroaki Araki
Journal:  Int J Clin Pharm       Date:  2016-01-08

2.  Patient related factors for optimal blood pressure control in patients with hypertension.

Authors:  Wang Yi-Bing; Kong De-Gui; Ma Long-Le; Wang Le-Xin
Journal:  Afr Health Sci       Date:  2013-09       Impact factor: 0.927

3.  Evaluation of a community pharmacy-based intervention for improving patient adherence to antihypertensives: a randomised controlled trial.

Authors:  Rosalind Lau; Kay Stewart; Kevin P McNamara; Shane L Jackson; Jeffery D Hughes; Gregory M Peterson; Diana A Bortoletto; Jenny McDowell; Michael J Bailey; Arthur Hsueh; Johnson George
Journal:  BMC Health Serv Res       Date:  2010-02-05       Impact factor: 2.655

4.  Challenges in measuring medication adherence: experiences from a controlled trial.

Authors:  Kay Stewart; Kevin P Mc Namara; Johnson George
Journal:  Int J Clin Pharm       Date:  2014-02

5.  Impact of Clinical Factors on the Achievement of Target Blood Pressure in Hypertensive Patients from Ivanovo Region of Russia: Data of 2015.

Authors:  A R Kiselev; O M Posnenkova; O A Belova; S V Romanchuk; Y V Popova; M D Prokhorov; V I Gridnev
Journal:  High Blood Press Cardiovasc Prev       Date:  2017-08-30

6.  General practitioners' hypertension knowledge and training needs: a survey in Xuhui district, Shanghai.

Authors:  Qian Chen; Xiangjie Zhang; Jie Gu; Tianhao Wang; Yuan Zhang; Shanzhu Zhu
Journal:  BMC Fam Pract       Date:  2013-01-28       Impact factor: 2.497

7.  Health behaviours, socioeconomic status and diabetes incidence: the Australian Diabetes Obesity and Lifestyle Study (AusDiab).

Authors:  E D Williams; R J Tapp; D J Magliano; J E Shaw; P Z Zimmet; B F Oldenburg
Journal:  Diabetologia       Date:  2010-08-26       Impact factor: 10.122

8.  HOMA insulin sensitivity index and the risk of all-cause mortality and cardiovascular disease events in the general population: the Australian Diabetes, Obesity and Lifestyle Study (AusDiab) study.

Authors:  E L M Barr; A J Cameron; B Balkau; P Z Zimmet; T A Welborn; A M Tonkin; J E Shaw
Journal:  Diabetologia       Date:  2009-11-07       Impact factor: 10.122

9.  Continuous relationships between non-diabetic hyperglycaemia and both cardiovascular disease and all-cause mortality: the Australian Diabetes, Obesity, and Lifestyle (AusDiab) study.

Authors:  E L M Barr; E J Boyko; P Z Zimmet; R Wolfe; A M Tonkin; J E Shaw
Journal:  Diabetologia       Date:  2009-01-08       Impact factor: 10.122

10.  Is there a link between components of health-related functioning and incident impaired glucose metabolism and type 2 diabetes? The Australian Diabetes Obesity and Lifestyle (AusDiab) study.

Authors:  Robyn J Tapp; Adrienne O'Neil; Jonathan E Shaw; Paul Z Zimmet; Brian F Oldenburg
Journal:  Diabetes Care       Date:  2009-12-10       Impact factor: 19.112

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.